Sinclair Dunlop
Founder and Managing Partner @ Masa Life Science Fund
Edinburgh, United Kingdom
Sinclair Dunlop is a Series A investor at Masa Life Science Fund in Edinburgh focused on Health Care and Therapeutics. Mr. Dunlop has twenty years of experience successfully partnering new technologies with and delivering competitive returns to international investors. Prior to co-founding Rock Spring Ventures, Mr. Dunlop successfully raised MASA Life Science Ventures, LP (“MLSV” – www.mlsvfund.com). MLSV’s investors include several leading institutions andcorporations in Japan and Korea, including a ‘top-ten’ Japanese Pharmaceutical company, the largest distributor of cardiac-health medical devices in Japan, a global financial institution and one of Japan’s leading publicly-traded Biotechnology companies. Mr. Dunlop’s international network of blue-chip co-investors, his experienced management team and a Scientific Advisory Board of renowned experts successfully built and managed a portfolio of leading life science companies. As Managing Partner of MLSV, he currently serves on the Board of Directors of Maxcyte Inc. and Apellis Pharmaceuticals Inc. He holds an M.B.A. from Columbia Business School, an M.A. (Honours) in Political Economy from Glasgow University, and a M.A. in International Relations from Syracuse University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sinclair Dunlop invests in
Stages Sinclair Dunlop invests in
Countries Sinclair Dunlop invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MediQuest is a specialty pharmaceutical / biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. | $23M / Series B / Jun 16, 2009 | ||
| MediQuest is a specialty pharmaceutical / biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. | $16M / Series A / Jun 15, 2006 |
Co-Investors
About Masa Life Science Fund
Masa Life Science Fund is a venture capital fund focused on investments in private, high-growth biotechnology, and life sciences companies.
Masa Life Science Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Sinclair Dunlop
Founder and Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sinclair Dunlop invest in?
Sinclair Dunlop invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sinclair Dunlop?
Public channels for Sinclair Dunlop include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sinclair Dunlop last invest?
The most recent investment recorded for Sinclair Dunlop closed in Jun 2009. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
